It would be of interest to further investigate whether IL-8 expression is mostly high in melanomas resistant to BRAF600/MEK inhibitors displaying the dedifferentiation phenotype, either shown originally by the resistant cells grown in the presence of a drug or induced by drug cessation in resistant melanomas that exert the differentiation phenotype. Here, CXCL8 is linked to melanoma.